Security key
21077P108
Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 71,405,968
- Share change
- -1,391,066
- Total reported value
- $43,712,940
- Price per share
- $0.61
- Number of holders
- 42
- Value change
- -$1,099,517
- Number of buys
- 8
- Number of sells
- 26
Report period
Q1 2025
Institutions
42
Top holders
10
CNTX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Context Therapeutics Inc. SEC filings
Context Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21077P108
Recent filing periods:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
16%
|
14,705,882
|
$15,441,176 | — | 31 Dec 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
8.2%
|
7,477,200
|
$7,851,060 | — | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
8.3%
from 13D/G
|
7,419,355
|
$7,790,323 | — | 31 Dec 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
8.1%
|
7,419,355
|
$7,790,323 | — | 31 Dec 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
6.9%
|
6,357,928
|
$6,675,824 | — | 31 Dec 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
5.1%
|
4,683,711
|
$4,917,897 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
4,003,380
|
$4,203,549 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
3,255,463
|
$3,418,237 | — | 31 Dec 2024 | |
| Blackstone Inc. |
13F
|
Company |
2.7%
|
2,440,330
|
$2,562,347 | — | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.1%
|
1,935,484
|
$2,032,258 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.8%
|
1,663,355
|
$1,746,523 | — | 31 Dec 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1.7%
|
1,576,762
|
$1,655,600 | — | 31 Dec 2024 | |
| Martin A. Lehr |
13D/G
|
Martin Lehr |
2.1%
|
1,595,742
|
$1,595,742 | $0 | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,361,350
|
$1,429,418 | — | 31 Dec 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.4%
|
1,328,352
|
$1,394,770 | — | 31 Dec 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.1%
|
1,015,340
|
$1,066,107 | — | 31 Dec 2024 | |
| Allostery Investments LP |
13F
|
Company |
1%
|
950,166
|
$997,674 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.99%
|
912,405
|
$958,025 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.76%
|
699,129
|
$734,086 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
628,729
|
$660,537 | — | 31 Dec 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.38%
|
351,094
|
$368,649 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.37%
|
338,435
|
$355,357 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.35%
|
322,838
|
$338,980 | — | 31 Dec 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.34%
|
308,758
|
$324,196 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.22%
|
203,286
|
$213,451 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
178,718
|
$187,654 | — | 31 Dec 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.18%
|
166,306
|
$174,621 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.17%
|
152,607
|
$160,237 | — | 31 Dec 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
125,852
|
$132,145 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
113,565
|
$119,243 | — | 31 Dec 2024 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$109,863 | — | 31 Dec 2024 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.1%
|
90,000
|
$94,500 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.1%
|
90,000
|
$94,500 | — | 31 Dec 2024 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.06%
|
57,804
|
$60,694 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
54,454
|
$57,177 | — | 31 Dec 2024 | |
| Aster Capital Management (DIFC) Ltd |
13F
|
Company |
0.06%
|
52,792
|
$55,432 | — | 31 Dec 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.05%
|
50,000
|
$52,500 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
29,900
|
$31,395 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
27,395
|
$28,765 | — | 31 Dec 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
27,122
|
$28,000 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
22,710
|
$23,846 | — | 31 Dec 2024 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
18,403
|
$19,324 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
16,668
|
$17,000 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
11,638
|
$12,000 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
10,500
|
$11,025 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,185
|
$10,694 | — | 31 Dec 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,500 | — | 31 Dec 2024 | |
| United Capital Management of KS, Inc. |
13F
|
Company |
0.01%
|
10,000
|
$10,500 | — | 31 Dec 2024 | |
| Tarek Sahmoud |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$8,415 | — | 16 Aug 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,257
|
$6,570 | — | 31 Dec 2024 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q1 2025
As of 31 Mar 2025,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,405,968 shares.
The largest 10 holders included
MPM BIOIMPACT LLC, Avidity Partners Management LP, Deep Track Capital, LP, Nextech Invest, Ltd., Blue Owl Capital Holdings LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Blackstone Inc., and Nantahala Capital Management, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
52
Q1 2025 holders
42
Holder diff
-10
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.